Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Classical hematology 1

Conditions

Anemia 3Squamous Cell Carcinoma of Head and Neck 2Head and Neck Neoplasms 2Uterine Cervical Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Fatigue 1Drug-Related Side Effects and Adverse Reactions 1Breast Neoplasms 1

Interventions

Cisplatin 31Brachytherapy 13Radiotherapy 12Paclitaxel 10Taxes 6Gemcitabine 6Platinum 51,2-diaminocyclohexaneplatinum II citrate 5Topotecan 4Radiotherapy, Intensity-Modulated 4Radiation 4Carboplatin 4Surgical Procedures, Operative 3Fluorouracil 3Cetuximab 3Vinorelbine 2Radiotherapy, Conformal 2Polymerase Chain Reaction 2Pemetrexed 2Chemotherapy, Adjuvant 2Celecoxib 2Capecitabine 2Amifostine 2sulfan blue 1oncogene protein E7, Human papillomavirus type 16 1iso-sulfan blue 1ethanethiol 1carfilzomib 1brivanib 1Vindesine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Uterine Cervical Neoplasms × Epoetin Alfa × Clear all
NCT00017004 2017-08-09

Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia

GOG Foundation

Phase 3 Completed
114 enrolled
Classical hematologyGynecologic

Anemia, Uterine Cervical Neoplasms, Radiation Injuries, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡